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Summary 
 
Objective 
To determine the prevalence and predictors of mood disorders, determined by structured clinical 
interviews (ICD or DSM criteria) in people after stroke.  
Methods 
Major electronic databases were searched from inception to June 2015 for studies involving major 
depression (MDD), minor depression (MnD), dysthymia, adjustment disorder, any depressive disorder 
(any depressive disorder) and anxiety disorders. Studies were combined using both random and fixed 
effects meta-analysis and results were stratified as appropriate.   
Results 
Depression was examined on 147 occasions from 2 days to 7 years after stroke (mean 6.87 months, 
N=33 in acute, N=43 in rehabilitation and N=69 in the community/ outpatients). Across 128 analyses 
involving 15,573 patients assessed for major depressive disorder (MDD), the point prevalence of 
depression was 17.7% (95% CI = 15.6% to 20.0%).65 analyses involving 9720 patients determined 
MnD was present in 13.1% in all settings (95% CI = 10.9% to 15.8%). Dysthymia was present in 3.1% 
(95% CI = 2.1% to 5.3%), adjustment disorder in 6.9% (95% CI = 4.6 to 9.7%) and anxiety in 9.8% 
(95% CI = 5.9% to 14.8%).  Any depressive disorder was present in 33.5% (95% CI = 30.3% to 
36.8%). The relative risk of any depressive disorder was higher following left (dominant) hemisphere 
stroke, aphasia, and among people with a family history and past history of mood disorders.  
 
Conclusion 
Depression, adjustment disorder and anxiety are common after stroke.Risk factors are aphasia, 
dominant hemispheric lesions and past personal / family history of depression but not time since 
stroke. 
 
Conflict of Interest: none to declare 
 
Funding: No funding was received by any authors relating to this paper. 
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Introduction  
 
Although standardised age rates of stroke mortality are decreasing across the world, the global 
burden of stroke (including years lived with disability) are substantial and continuing to increase.
1
 
Improvements in medical treatment have increased the number of people surviving and living with the 
consequences of stroke.
2
 Depression is particularly problematic and persistent after stroke, with high 
risk of relapse, even after a long period of remission.
3
 People with depression after stroke experience 
greater impairment, including more substantial reductions in activities of daily living, 
4
 
5
 
6
 poorer quality 
of life
7
 and increased mortality,
8
 
9
 compared with non-depressed stroke patients. Untreated post-
stroke depression often impairs physical rehabilitation and recovery.
10
 
11
 
12
  Depression has also been 
proposed to have a bidirectional relationship with stroke, being cause by stroke and also acting as a 
risk factor for stroke itself.
13
 Despite the clear importance of depression after stroke, there is evidence 
suggesting it is under-recognised.
 14
 
 
Beyond depression, other mood disorders have been much less extensively investigated. For 
example, the proportion suffering dysthymia, anxiety disorders or adjustment disorder is essentially 
unknown. Further to this, although there has been considerable interest in risk factors for post-stroke 
depression the most commonly investigated factors, namely aphasia and lesion location, remain 
controversial. Four previous systematic reviews or meta-analyses have examined the importance of 
lesion location with varying results.
15
 
16
 
17
 
18
 All these reviews included heterogeneous types of 
depression, defined by self-report scales alone as well as robust interviews. Indeed despite many 
narrative reviews of post-stroke depression, none have focussed on robust interview based studies.
19
  
Two previous meta-analyses also considered the prevalence of depression post stroke, but did not 
confine the studies included based on robust interviews and were not able to investigate the 
prevalence of other mood disorders that may also be problematic post stroke (e.g. dysthymia, anxiety 
disorders or adjustment disorder).
20
 
21
 One recent meta-analysis looked at anxiety disorders with 
similar limitations.
22
  An unresolved question is whether mood disorders remain elevated during 
rehabilitation and discharge back to the community. If rates of depression and anxiety remain high 
then clinicians should continue to monitor such patients long after their inpatient treatment has 
concluded.  We therefore set out to address the shortcomings in the literature and establish the 
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4 
prevalence of mood disorders (major depression, minor depression, dysthymia) as well as adjustment 
disorder, anxiety disorders and combined mood disorders post stroke.  We also set out to examine 
the underlying influences upon depression by stratifying studies by setting, aphasia, lesion location, 
family history, personal history and time since stroke. 
 
Methods 
This review was conducted in accordance with the Meta-analysis of Observational Studies in 
Epidemiology (MOOSE)
23
 guidelines and with reference to the preferred items for reporting 
systematic reviews and meta-analysis (PRISMA) statement
24
 following a predetermined protocol 
available on request (PRISMA criteria #5). . MOOSE and PRISMA compliance checklists are 
available in appendix 3 and 4.  
 
Eligibility criteria 
Studies were included that 1) reported the prevalence of depression and related mood or anxiety 
disorders in adults who had experience a stroke within a consecutive, random or convenience sample 
on at least one occasion according to the definitions within the ICD or DSM criteria (typically two 
weeks).  This included cross sectional and longitudinal studies.  2) Determined the presence of 
depression, mood and anxiety disorders through robust interview including structured, semi-structured 
or a clinical interview applied by a researcher, trained clinician or health professional. 3) Were 
conducted in acute (inpatient hospital) care, rehabilitation and in the community. Unless predefined by 
authors, we defined acute care as 0-1 months, in accord with typical length of stays after stroke of 14-
21 days.
25
 
26
 Stroke itself was defined by ICD160–169 (non-traumatic intracranial hemorrhage, 
cerebral infarctions and occlusion and stenosis of cerebral or pre-cerebral vessels without infarction).  
We considered the following disorders meeting the following DSM research criteria: A. Major 
depressive disorder (MDD) defined by interview against DSM (III,IIIR,IV) criteria. B. Minor depressive 
disorder (MnD) as listed in DSM (III,IIIR,IV,IV-TR) under Depressive Disorder Not Otherwise 
Specified). C. Dysthymia according to DSM (III,IIIR,IV) research criteria. D. Adjustment disorder 
(either alone or comorbid) by DSM (III,IV) research criteria E. Any depressive disorder , that is 
syndromal (clinical) depression defined by formal interview and including at least two subtypes of 
depression defined in DSM (III,IIIR,IV,IV-TR) research criteria F. Anxiety disorders (generalized 
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5 
anxiety disorder was examined by all such studies but a minority also considered 
agoraphobia, panic disorder, agoraphobia, OCD and social phobia) by DSM (III,IIIR,IV) 
criteria.G. Mood comorbidity that is a combination of depression and anxiety with or without 
adjustment disorder.  
 
Studies were excluded that a) relied upon self-report or observer scales to quantify depression 
including those using a two-step procedure of an initial scale and then interview in those who screen 
positive in step 1. b) Were not representative of the general stroke population including those among 
selected samples (e.g. from interventional trials or those below the age of 18).  c) Studies only 
reporting lifetime prevalence of mood disorder.  We also excluded duplicate publications; that is two 
or more studies on the same sample collected at the same time point. However we allowed multiple 
analyses by time from one publication (for example assessment at 1, 3 and 12 months).  However, we 
performed restrictor moderator analysis in order to address the influence of this, counting only unique 
individuals. We did not place any language restriction upon eligible studies.  We refer to the period 
prevalence (for example the last two weeks) hereafter simply as “prevalence”.   
 
Literature search  
Two independent authors (AJM, NM) conducted searches of Medline (Pubmed), PsycINFO and Web 
of Knowledge from inception to June 2015.  We used the key words (stroke or cerebrovascular or 
hemorrhage or cerebral infarctions) and (depression, major depression, major depressive disorder, 
minor depressive disorder, dysthymia, adjustment disorder, anxiety, panic, generalized anxiety, social 
anxiety, phobia, mood and emotion$). In addition, we conducted hand searches of the references lists 
of included articles and contacted numerous International experts to ensure completeness of data 
acquisition.  This was supplemented by online searches of key journals (American Journal of 
Psychiatry, Neurology, JNNP, Stroke, American Journal of Geriatric Psychiatry, British Journal of 
Psychiatry).  Where possible we reviewed the full text version. For qualifying studies wherever 
possible we attempted to acquire the required data directly from the primary authors of included 
studies.  The search strategy is shown in appendix 1. 
 
Quality assessment and Risk of bias assessment 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
6 
Two authors (JSG, AJM) conducted the risk of bias assessment using a four point quality rating and a 
five point bias risk was applied to each study as used in a recent similar prevalence study.
27
 The 
quality rating score was based on study sample size, study design, study attrition, follow-up (if any) 
and method of dealing with possible confounders with the following scale: 1 = low quality 2 = low-
medium quality 3 = medium – high quality 4 = high quality. The bias rating score evaluated possible 
bias in assessments of results as influenced by consideration of setting, aphasia, interview method 
and sampling method. Bias was rated with the following score: 0 = no appreciable bias risk 1 = low 
bias risk 2 = low to medium bias risk 3= medium to high bias risk 4 = high bias risk. Finally the 
sampling method was evaluated for each study, as this influences the interpretation of prevalence 
data (see below). Any area of disagreement was resolved by two supervisors (AJM, NM).  
 
Data extraction 
Three independent authors (JG, BS, AJM) conducted all data extraction using a standard extraction 
form.  The data extracted included study design, setting, participant characteristics (number, mean 
age, gender, details of any cognitive assessment e.g. Mini-Mental State Examination (MMSE)), type 
of mood disorder and classification criteria used, details of stroke, (including time since the event, 
type and hemispheric laterality) the prevalence of aphasia and family and personal history of mood 
disorders studies.  
 
Statistical Analysis 
Prevalence and relative risk meta-analyses were calculated. Heterogeneity was defined by I² statistic 
Which describes the percentage of variation across studies that is due to heterogeneity rather than 
chance and does not inherently depend upon the number of studies considered (Higgins et al., 2003).
 
28
 Due to the moderate and high inconsistency/ heterogeneity (I
2
 of ≥80% = moderate ≥90% = high 
respectively) data was pooled using DerSimonian-Laird random effects meta-analysis with StatsDirect 
(version 2.7.7).  In order to assess for publication bias we conducted the Harbord bias test.
29
  Harbord 
test maintains the power of the Egger test whilst reducing the false positive rate.  
In assessing the association between linear variables we used spearman correlation with adjusted R
2
. 
Regarding predictors and correlates of mood disorder we stratified sub analysis and meta-regression. 
We examined the effect of age, gender, setting, stroke type and time since stroke. The failsafe 
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7 
number of studies that would justify meta-analysis in any subsection, was set at three, according to 
convention of the Cochrane collaboration. A meta-regression was conducted for the effect of time 
since stroke on prevalence using Restricted Maximum Likelihood (REML) estimate of between study 
variance explained by time with Knapp-Hartung modification for small samples 
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Results 
The initial searches yielded 2658 hits on pubmed, 1,168 hits on Web of Knowledge and 883 on 
PsychINFO (1833 after removal of duplicates) but upon review only 419 were relevant after initial 
screening (see PRISMA flowchart appendix 2). From 419 articles reviewed in detail following 
application of the eligibility criteria: a total of 108 publications were included that examined the 
prevalence of depression among 14,220 unique patients who had experienced a stroke (references of 
included articles are presented in appendix 5).  Details of the search strategy and breakdown of the 
study characteristics are summarized in figure 1. Considering each assessment in time as separate 
analysis meant that depression was examined on 147 occasions from 2 days to 7 years after stroke 
(mean 6.87 months) across the studies.  
Insert figure 1 here 
 
Study and participant characteristics 
Of 147 included analyses (in 108 publications), 33 took place in an acute hospital setting, 43 in 
rehabilitation settings and 69 in the community or hospital outpatient settings (see appendix table 2 
for full details). The mean age of stroke patients across all studies was 65.0 years, and 43.8% were 
female. 42 studies conducted the MMSE in their sample and the mean MMSE score among 5539 
patients was 25.8.  Of the included studies, 16 offered prospective assessment of depression at least 
two points after stroke. 128 analyses reported on the prevalence estimates of major depression 
(n=15,573), 65 on minor depression (n=9720), 75 on major or minor depression combined 
(n=10,799), 25 reported rate of anxiety disorders (n=2974), largely mixed types or generalized anxiety 
disorder), and 18 reported rates of dysthymia (n= 3320), and 8 reported on adjustment disorder (n= 
1849).  A subset of analyses looked at regional stroke location, most commonly hemisphere laterality 
(N=44, n=6115). 55 analyses considered only cerebral ischaemic stroke (n=7386), the remainder 
considered mixed types of stroke. Of studies reporting types of stroke approximately 83% had 
ischaemic thromboembolic stroke. 95 analyses assessed and excluded people with aphasia and only 
5 studies specifically reported on the prevalence of depression in stroke patients with aphasia.  Full 
details of each study are presented in online appendix table 2.  
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9 
Quality assessment of the included studies is summarized in online appendix 2. 24.1% of studies had 
a low quality.  The most common reasons for low quality were using an unstructured clinical interview, 
not fully reporting data and low sample size. Regarding risk of bias, 13% of studies had a high risk of 
bias. The most common risk identified among the studies included not reporting blinding of 
assessments, using single stroke types, not reporting pre-defined cut-offs for diagnostic thresholds, 
and a lack of information concerning drop outs.  
 
Overall pooled prevalence of any disorder of mood or emotion 
The overall pooled prevalence of any disorder of mood or emotion across all settings was 27.0% 
(95% CI = 21.8% to 32.3%).  The pooled prevalence of any disorder of mood or emotion was 31.6% 
(95% CI = 20.6% to 43.7%), 25.4% (95% CI = 17.8% to 33.7%) and 26.7% (95% CI = 19.0% to 
35.2%) in acute, rehabilitation and community settings respectively.  The pooled prevalence of each 
disorder are summarized in table 1.   
Insert table 1 here 
Prevalence of Depression 
1.  DSM Major Depression 
In total, the pooled prevalence of MDD across 128 analyses (n=15,573) measured a mean of 6.9 
months after stroke, was 17.7% (95% CI = 15.6% to 20.0%,). There was evidence of publication bias 
in this sample with a lower than expected number of small studies showing a small proportion with 
depression (p = 0.01). The prevalence of MDD among studies including people with aphasia was 
14.3% (95% CI = 11.1% to 17.8%) and 19.9% (95% CI = 17.3% to 22.6%) in those analyses with 
aphasia excluded. When restricted to a non-overlapping sample of 12,723 unique individuals in 98 
studies, then the prevalence was 19.2% (95% CI = 16.6% to 22.0%).   
 
It was possible to pool 32 analyses (n=3838) examining MDD in the acute post-stroke period, a mean 
of 3.4 weeks after stroke. This established a pooled prevalence of post-stroke MDD of 18.1% (95% CI 
= 14.4% to 22.1%) (figure 2).  Sub group analysis revealed that this estimate was not statistically 
different in studies that included or excluded aphasic patients or restricting the analyses to non-
overlapping samples of unique individuals.  Next, we pooled 42 analyses (n=3444) examining MDD in 
rehabilitation settings, a mean of 7.1 months after stroke. The prevalence of post-stroke MDD was 
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10 
20.0% (95% CI = 16.3% to 24.1%). It was 17.8% (95% CI = 12.8% to 23.4%) in those studies with 
aphasia included and 21.4% (95% CI = 16.3% to 26.9%) in those analyses with aphasia excluded. 
Results were almost identical when restricted to non-overlapping sample.  Full details of the analysis 
are displayed in table 1.  
 
Insert figure 2 here 
 
56 analyses (n=8557) examined MDD in a patients in community settings, a mean of 10.0 months 
after stroke. The point prevalence of depression was 15.8% (95% CI = 12.7% to 19.2%). The pooled 
prevalence of MDD was 12.4% (95% CI = 8.7% to 16.7%) in those studies with aphasia included and 
18.7% (95% CI = 14.6% to 23.3%) in those analyses with aphasia excluded. When restricted to a 
non-overlapping sample of 5960 unique individuals) the prevalence was 18.0% (95% CI = 13.1% to 
23.4%). 
 
2. DSM Minor Depression 
In total 65 analyses (n=9720) examined MnD across all settings establishing a prevalence of 13.2% 
(95% CI = 10.9% to 15.8%). This was 12.6% (95% CI = 10.2% to 15.2%) in those without aphasia 
and 15.7% (95% CI = 10.2% to 22.1%) in those that did not exclude aphasia.  18 analyses (n=2386) 
examined MnD in an acute hospital setting, a mean of 3.4 weeks after stroke. The prevalence of post-
stroke MnD was 10.9% (95% CI = 7.4% to 14.9%). Further details of subgroup analysis according to 
the setting are presented in table 1.   
 
Anxiety disorder 
The pooled prevalence of anxiety disorder across all settings (N=25, n=2974) was 9.8% (95% CI = 
5.9% to 14.8%).  The pooled prevalence in acute setting was 10.7% (95% CI = 3.8% to 20.4%), whilst 
7.0% (95% CI = 3.4% to 11.7%) and 12.8% had anxiety in rehabilitation and community setting 
respectively.   
 
Adjustment disorder 
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11 
The pooled prevalence of adjustment disorder was calculated from 8 analysis (n=1849) across all 
settings at 6.9% (95% CI = 4.6% to 9.7%).  Due to limited data it was not possible to conduct 
subgroup analysis among people with adjustment disorder across different settings.   
 
Dysthymia 
The pooled prevalence of dysthymia across all settings was 3.6%.  The pooled prevalence was 
highest in acute settings (8.4%, 95% CI = 1.59% to 19.9), followed by rehabilitation (5.1%, 95% 
CI=1.73% to 10.1) and community settings (2.3%, 95% CI= 1.1-3.9%).   
 
Predictors of Post-Stroke Depression  
1. The Effect of Hemispheric Laterality 
In patients with a stroke affecting the left hemisphere (across all time periods and settings) (N=19, 
n=1887) MDD was present in 34.3% (95% CI = 24.8% to 44.4%). This was significantly higher than 
the rate of MDD after stroke irrespective of lesion site (17.7%, 95% CI = 15.6% to 20.0%, see above). 
A relative risk analysis of MDD after left hemisphere lesions vs MDD after non-left hemisphere lesions 
was conducted and had no evidence publication bias or hetergeneity (figure 3). Given the low 
heterogeneity a fixed effects meta-analysis showed that the risk of MDD was 1.50 (95% CI = 1.29 to 
1.74, Chi² = 27.4, P < 0.0001) following left vs non-left lesions. This effect was also significant using 
random effects meta-analysis (data not shown). 
 
Insert figure 3 about here 
 
20 analyses involving 3618 patients examined whether the prevalence of any depressive disorder 
was influenced by hemishpere laterality. In those with a left hemisphere stroke the rate of any 
depressive disorder was 41.1% (95% CI = 37.4% to 44.8%). This was significantly higher than the 
rate of any depressive disorder depression after stroke irrespective of lesion site (33.5% (95% CI = 
30.3% to 36.8% see above). A relative risk analysis of any depressive disorder after left hemisphere 
lesions vs depression after non-left hemisphere lesions was conducted and had no evidence 
publication bias or hetergeneity. On fixed effects meta-analysis the risk of any depressive disorder 
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was 1.26 (95% CI = 1.16 to 1.37, Chi² = 27.4, P < 0.0001) following left vs non-left lesions. This effect 
remained statistically significant using random effects meta-analysis (data not shown). 
 
2. The Effect of Aphasia 
Only four analysis involving 113 patients examined MDD in stroke patients with clearly defined 
aphasia (all settings and all time periods) were available and the pooled prevalence of MDD in 
aphasic patients was 30.5% (95% CI = 10.1% to 56.1%). There was insufficient data to perform a 
relative risk analysis because only two studies reported on the rate of depression in stroke patients 
with vs without aphasia in their sample.  
 
Only five analysis involving 211 patients examined any depressive disorder in stroke patients with 
aphasia (all settings and all time periods). The prevalence of any depressive disorder in aphasic 
patients was 52.2% (95% CI = 34.9% to 69.3%) There was a 50% increased risk of depression in 
stroke patients with vs without aphasia (RR 1.50, 95% CI = 1.28 to 1.75). 
 
3. The Effect of Family History of Mood Disorders 
Eight studies involving 1099 patients examined the influence of family history on the prevalence of 
depression after stroke. In those with a family history there was a 27.3% rate (95% CI = 17.4% to 
38.5%) of any depressive disorder vs 20.0% (95% CI = 13.2% to 27.6%) in those without a family 
history. The relative risk of depression was 1.44 (95% CI = 1.15 to 1.80).  
 
4. The Effect of Past History of Mood Disorders 
Eight studies involving 1058 patients examined the influence of family history on the prevalence of 
depression after stroke. In those with a past history there was a 22.4% (95% CI = 15.2% to 30.5%) of 
any depressive disorder vs 12.8% (95% CI = 9.9% to 16.1%) in those without a personal past history. 
The relative risk of depression was 1.80 (95% CI = 1.36 to 2.38). 
 
5. The Effect of Time Since Stroke 
The most frequent occasion after stroke when depression was measured was 12 months, when the 
prevalence of MDD was 13.4% (95% CI = 9.6% to 17.8%) and the prevalence of any depressive 
disorder was 23.9% (95% CI = 18.5% to 29.8%). We conducted a meta-regression concerning the 
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effect of time since stroke on the prevalence of depression (figure 4) and anxiety (figure 5). Looking at 
MDD there was a non-significant decrease in prevalence of depression by time (coefficient = -0.01; 
t=-1.30 p=0.196). There were similar findings for any depressive disorder MnD and anxiety.  
 
Insert figure 4 and 5 here 
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Discussion 
To our knowledge, this is the first study to examine the prevalence and predictors of post-stroke 
depression / anxiety / adjustment disorder using meta-analysis solely based upon interview defined 
clinical disorders. Across 128 analyses of post-stroke major depression, the point prevalence of 
depression was 17.7% (95% CI = 15.6% to 20.0%) although this was 19.2% when restricted to unique 
sample of 12,723 individuals in 98 non-overlapping studies. Results were broadly equivalent in 
different settings, varying from 15.8% in community/outpatient settings and 20.0% in rehabilitation 
settings. These prevalence estimates are similar to the rates of major depression defined by interview 
in large scale meta-analyses in primary care (17·3%, 12·2% to 23·1%)
30
 and cancer (14·9%, 12·2–
17·7%).
31
  However, it is important to recognise major depression is only one of several important 
mood disorders. Minor depression and other non-major depressions are associated with significant 
burden 
32
 and previous meta-analyses have failed to consider the range of mood disorders.  We found 
65 analyses involving 9720 patients that examined MnD, across all settings and found that MnD was 
present in 13.1% (13.3% in unique patient analysis) although it was particularly high as 16.7% in 
rehabilitation settings. An additional 3.1% had dysthymia and 6.9% had adjustment disorder. Overall 
we estimate that at least one in three have clinical depression (any depressive disorder) on any 
particular day after stroke.  The clinical implication is that clinicians should be vigilant for depression 
after stroke and further routine screening may be worth considering. This is comparable to previous 
meta-analyses that have not confined their results to robust interview defined clinical disorders.
20 21
 
One recent meta-analysis examined anxiety disorders but included mixed scales and only 8 studies 
involved objective methods. We expand upon this to involve 25 studies of anxiety disorders.
22
 When 
examined cross-sectionally, at precisely 12 months, we found that 13.5% had MDD and 23.9% any 
depressive disorder using pooled data. The clinical implication is that even a year after stroke, 
depression is significant. Future research should investigate the long-term burden of depression on 
patients and families. 
 
Relatively few studies have examined anxiety disorders using interview methods. Of those, the 
prevalence of anxiety disorders was 9.9% (95% CI = 5.9% to 14.8%) with no clear difference in 
particular settings but 11.7% in a re-analysis using a non-overlapping sample. This is quite likely to be 
an underestimate, in part because not all studies measure all types of anxiety disorder, partially 
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because depressive disorders receive most clinical attention and partially because criteria for GAD 
are currently very restrictive, requiring at least 6 months duration (note that some authors have 
purposely omitted this).
33
 Unfortunately, the clinical significance of anxiety disorders after stroke, for 
example effect on daily function, effect on long-term recovery and interaction with  major depression 
remains under studied. Once combined, the prevalence of any disorder of mood or emotion appears 
to be at least 30% although this is not a case of simple addition of the aforementioned categories 
because many types of mood disorder are comorbid. Future research should investigate not just the 
prevalence but also the impact of anxiety on rehabilitation and mortality. 
 
We were only able to study possible risk factors for MDD, any depressive disorder and anxiety after 
stroke. There was insufficient data to study disease burden which appears influential according to 
previous research.
34
 
35
 
36
 The relative risk of MDD was 50% higher (RR=1.50, 95% CI = 1.29 to 1.74) 
and the relative risk of any depressive disorder was 26% higher (RR=1.26, 95% CI = 1.16 to 1.37) 
following left (dominant) hemisphere stroke. Lesions in the dominant hemisphere generally cause 
more disability and a high chance of communication difficulties. Perhaps unsurprisingly therefore, the 
relative risk of any depressive disorder was 50% higher following aphasia (RR = 1.50, 95% CI = 1.28 
to 1.75). The prevalence of MDD was higher in aphasic vs non- aphasic patients was 30.5% vs 19.9% 
but this did not reach statistical significance. Two other risk factors appeared to be important for post-
stroke depression. The relative risk of any depressive disorder was 1.44 (95% CI = 1.15 to 1.80) if 
there was a family history of mood disorders and 1.80 (95% CI = 1.36 to 2.38) if there was a prior 
history of mood disorder. Regarding the effect of time since stroke, this was suprisingly weak. There 
was a non-significant decrease in prevalence of MDD by time (t=-1.30 p=0.196). A similar non-
significant decrease was found for any depressive disorder, MnD and anxiety. Several other groups 
have examined the predictors of post-stroke depression using self-report depression scales. White et 
al (2011) found that the prevalence of depression in 2,477 participants at 4 months after stroke was 
19%
37
 and contrary to our results, they found that risk of depression reduced by duration post-stroke. 
The clinical implication is that left (dominant) hemisphere stroke, aphasia, personal history and family 
history of mood disorders are the predominant known risk factors. Time since stroke is a weak risk 
factor and as such a high index of suspicions should be maintained even 5 years after a stroke, 
particularly where neurological complications persist. 
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We acknowledge the following limitations, which are largely accounted for by limitations in the primary 
studies. Despite the large sample size there were inadequate data in some subgroups and in some 
mood disorders, particularly adjustment disorders. There was also inadequate data to examine 
several potentially useful predictors of mood disorders such as disability, gender and quality of life 
and receipt of antidepressants; these should ideally be addressed in future studies. We acknowledge 
considerable heterogeneity in the sample and occasional evidence of publication bias (see table 1). 
There were variations in the handling of aphasia, although we attempted to allow for this by clarifying 
if studies included or excluded patients with communication difficulties. Few studies attempted to 
quantify severity of dysphasia and only nine studies (4 MDD 5 any depressive disorder) specifically 
reported on prevalence in aphasic patients. It is possible that aphasia reduces the ability to perform 
structured interviews, reducing recruitment and possibly leading clinicians to rely on somatic 
symptoms such as agitation or retardation.  A further limitation concerned the definition of mood 
disorders. Although we focussed on interview based definition  using a structured, semi-structured or 
a clinical interview there was still considerable variation in type and quality of this interview. This could 
have introduced variations in prevalence according to the assessment method. Further almost all 
studies examined point prevalence, meaning that transitions in to and out of remission were poorly 
described as were the total number of cases developing over a period of time (cumulative 
prevalence). We also note that stroke patients often have a high burden of physical symptoms and 
symptoms such as fatigue, anorexia and psychomotor retardation which may be caused by stroke or 
alternatively by depression. As such the phenomenology of post-stroke depression may be different to 
non-comorbid depression. That said most studies have found only minor differences in presentation.
38
 
39
 . Finally, we only searched three electronic databases.   
 
We conclude post-stroke disorders of mood or emotion appear to be common and highly comorbid. 
Prevalence estimates do not appear to vary significantly with time but are typically higher in 
rehabilitation settings than in community settings. The key risk factors for post-stroke depression 
appear to be a past history of depression, a family history of depression, aphasia and left hemisphere 
lesions. Contrary to some previous reviews,
15 16 17 18
 this more thorough quantitative analysis shows 
that lesion location is important for post-stroke depression but it is only one of many risk factors. The 
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UK National Clinical Guidelines for Stroke recommend screening for depression within the first month 
of a stroke event; however, compliance with this is inconsistent.40 Given the persistent nature of post-
stroke mood disorders we recommend clinical assessment and routine screening is extended to one 
year. We also recommend clinicians look for broadly defined mood disorders, anxiety and distress, 
not just major depression alone.  
 
 
 
Appendix 1 Search strategy (including search terms) 
Appendix 2 PRISMA flowchart 
Appendix 3 Moose Checklist 
Appendix 4 Prisma Checklist 
Appendix 5 Qualifying study list 
 
 
ACCEPTED MANUSCRIPT
AC
CE
PTE
D M
AN
US
CR
IPT
 
18 
Summary Table 1 – Statistical Summary of the Prevalence of Mood and Anxiety Disorders after Stroke by Setting 
  Acute Hospital Rehabilitation Community / Outpatient Overall (all settings) 
Major Depression (DSM) 
 
Prevalence 
(CI) 
18.1%  
(95% CI = 14.4% to 22.1%) 
20.0%  
(95% CI = 16.3% to 24.1%) 
15.8%  
(95% CI = 12.7% to 19.2%) 
17.7%  
(95% CI = 15.6% to 20.0%) 
 Inconsistency 89.1%  
(95% CI = 86.1% to 91.2%) 
87.9%  
(95% CI = 85.0% to 90.1%) 
94.1%  
(95% CI = 93.3% to 94.8%) 
92.1%  
(95% CI = 91.3% to 92.8%) 
 Harbord bias -0.12  
(92.5% CI = -3.36 to 3.12)  
P = 0.95 
2.52  
(92.5% CI = -0.33 to 5.37) P = 
0.11 
2.70  
(92.5% CI = 0.17 to 5.22) P = 
0.06 
2.27  
(92.5% CI = 0.78 to 3.76)  
P = 0.01 
      
Minor Depression (DSM) Prevalence 
(CI) 
10.9%  
(95% CI = 7.4% to 14.9%) 
16.7%  
(95% CI = 11.1% to 23.3%) 
12.6%  
(95% CI = 9.3% to 16.3%) 
13.2%  
(95% CI = 10.9% to 15.8%) 
 Inconsistency 87.8%  
(95% CI = 82.6% to 90.9%) 
92.1%  
(95% CI = 89.5% to 93.7%) 
93.1%  
(95% CI = 91.4% to 94.2%) 
91.9%  
(95% CI = 90.7% to 92.9%) 
 Harbord bias 0.70  
(92.5% CI = -2.74 to 4.15)  
P = 0.70 
1.49  
(92.5% CI = -4.00 to 6.99)  
P = 0.61 
-2.27  
(92.5% CI = -5.82 to 1.27)  
P = 0.25 
-0.37  
(92.5% CI = -2.53 to 1.78)  
P = 0.75 
      
Any Depression (DSM or ICD) 
(Major or minor or dysthymia 
Prevalence 
(CI) 
33.9%  
(95% CI = 29.0% to 39.0%) 
43.6%  
(95% CI = 34.5% to 52.9%) 
28.5%  
(95% CI = 24.7% to 32.5%) 
33.5%  
(95% CI = 30.3% to 36.8%) 
 Inconsistency 88.6%  
(95% CI = 84.9% to 91.1%) 
94.9%  
(95% CI = 93.9% to 95.7%) 
93.1%  
(95% CI = 92% to 94%) 
93.6%  
(95% CI = 92.9% to 94.1%) 
 Harbord bias -0.35  
(92.5% CI = -3.61 to 2.92) 
P = 0.85 
2.26  
(92.5% CI = -1.90 to 6.43)  
P = 0.32 
0.071  
(92.5% CI = -2.80 to 2.94) 
P = 0.96 
1.45  
(92.5% CI = -0.38 to 3.29)  
P = 0.16 
      
Any Anxiety Disorder (DSM or 
ICD) 
Prevalence 
(CI) 
10.7%  
(95% CI = 3.8% to 20.4%) 
7.0%  
(95% CI = 3.4% to 11.7%) 
12.8%  
(95% CI = 11.3% to 14.3%) 
9.8%  
(95% CI = 5.9% to 14.8%) 
 Inconsistency 90.7%  
(95% CI = 70.8% to 95.2%) 
74.6%  
(95% CI = 37.5% to 85.8%) 
96.3%  
(95% CI = 95.3% to 96.9%)  
 
94.4%  
(95% CI = 93.1% to 95.3%) 
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 Harbord bias 13.83  
(92.5% CI = -42.54 to 
70.20) 
P = 0.29 
6.71  
(92.5% CI = 2.09 to 11.34) 
P = 0.02 
-5.13  
(92.5% CI = -14.24 to 3.97) 
P = 0.29 
-2.22  
(92.5% CI = -7.82 to 3.38) 
P = 0.47 
      
Adjustment Disorder (DSM or 
ICD) 
Prevalence 
(CI) 
Insufficient Data Insufficient Data Insufficient Data 6.9%  
(95% CI = 4.6% to 9.7%) 
 Inconsistency Insufficient Data Insufficient Data Insufficient Data 72.3%  
(95% CI = 34.3% to 84.3%) 
 Harbord bias Insufficient Data Insufficient Data Insufficient Data 3.41  
(92.5% CI = 1.68 to 5.14) P = 
0.0045 
      
Dysthymia (DSM or ICD) Prevalence 
(CI) 
8.4%  
(95% CI = 1.59% to 19.9%) 
5.1%  
(95% CI = 1.73% to 10.1%) 
 
2.3%  
(95% CI = 1.1% to 3.9%) 
3.6%  
(95% CI = 2.1% to 5.4%) 
 Inconsistency 82.2%  
(95% CI = 0% to 92.4% 
69.1%  
(95% CI = 0% to 85.9%) 
79.4%  
(95% CI = 60.9% to 87.0%) 
81.6%  
(95% CI = 71.7% to 86.9%) 
 Harbord bias 10.03  
(92.5% CI = -54.53 to 
74.59)  
P = 0.41 
5.70  
(92.5% CI = 0.39 to 11.01)  
P = 0.06 
3.99  
(92.5% CI = 1.33 to 6.64)  
P = 0.01 
4.89  
(92.5% CI = 2.69 to 7.10)  
P = 0.0006 
      
Any Mood Disorder (DSM or ICD) Prevalence 
(CI) 
31.6%  
(95% CI = 20.6% to 43.7%) 
25.4%  
(95% CI = 17.8% to 33.7%) 
26.7%  
(95% CI = 19.0% to 35.2%) 
27.0%  
(95% CI = 21.8% to 32.3%) 
 Inconsistency 89.2%  
(95% CI = 61.3% to 94.7%) 
80.5%  
(95% CI = 60.1% to 88.1%) 
94.1%  
(95% CI = 92% to 95.4%) 
91.2%  
(95% CI = 88.6% to 92.9%) 
 Harbord bias 3.64  
(92.5% CI = -89.67 to 
96.95)  
P = 0.80 
4.43  
(92.5% CI = -0.66 to 9.53)  
P = 0.11 
-2.29  
(92.5% CI = -10.09 to 5.52)  
P = 0.58 
-0.91  
(92.5% CI = -4.65 to 2.84)  
P = 0.66 
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Figure 1 – Quorum figure of study count 
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Figure 2 – Prevalence of Post-Stroke Depression in Acute Settings 
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Figure 3 – Relative Risk of Major Depression after left hemisphere stroke 
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Figure 4 – Meta-regression: major depression prevalence estimate and time since 
stroke (in months) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 – Meta-regression on anxiety prevalence estimate and time since stroke in 
months 
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Table 2 
Author New 
quality 
rating 
score  
New 
bias 
rating 
score  
Year Aphasia 
excluded 
Total 
sample 
with 
Stroke 
Age 
(Mean). 
Setting Method of defining depression Operational criteria Gender 
(Female 
%) 
Country 
Aben et al 
(1999) 
4 1 2002 Y 202 68.5 Hospital inpatients SCID DSMIV MDD+MnD 45.50% Netherlands 
Aben et al 
(2002) 
4 1 2002 Y 190 68.6 Hospital Outpatients SCID DSMIV MDD+MnD 46.80% Netherlands 
Aben et al 
(2006)  
4 1 2006 Y 189 68.6 Hospital Outpatients SCID DSMIV MDD+MnD 47% Netherlands 
Agrell and 
Dehlin (1994) 
3 1 1994 Y 93 76.5 Geriatric rehabilitation clinic SCID DSMIIIR MDD+MnD 42% Sweden 
Agrell et al 
(1989) 
2 3 1989 Y 40 80 outpatient, rehabilitation, 
nursing home 
Unstructured Clinical Interview DSMIIIR MDD+MD 55% Sweden 
Altieri et al 
(2012) 
4 1 2012 Y 105 64.4 Stroke rehabilitation unit in 
hospital 
SCID DSMIV MDD+MnD 34% Italy 
Appelros et al 
(2004) 
3 1 2004 N 251 74.5 Hospital Outpatients SCID DSMIV MDD+MnD 50.90% Sweden 
Åström et al 
(1993)  
4 1 1993 N 73 73 Hospital Outpatients Psychiatric diagnostic interview DSMIII MDD 39% Sweden 
Åström et al 
(1996)  
4 1 1996 N 70 73 Stroke rehabilitation unit in 
hospital 
SCID DSMIIIR MDD 39% Sweden 
Berg et al 
(2009) 
2 3 2009 N 100 55 Hospital inpatients Unstructured Clinical Interview DSMIIIR MDD 32% Finland 
Bolla-Wilson et 
al (1989) 
3 1 1989 Y 53 59.6 Acute   Present State Examination DSMIII MDD NR US 
Bossu et al 
(2009) 
2 2 2009 N 30 66.43 Inpatient stroke unit Research Diagnostic criteria 
(RDC)  
DSMIVTR 
MDD+MnD 
47% Italy 
Bour et al 
(2010) 
4 1 2010 Y 138 66.1 Hospital Outpatients SCID DSMIV MDD+MnD 48% Netherlands 
Brodaty et al 
(2007)  
4 1 2007 Y 135 72.01 Community follow-up from 
Inpatient stroke unit 
SCID DSMIV MDD+MnD 43% Australia 
Bryer et al 
(1992) 
2 2 1992 Y 20 55.3 Hospital inpatients Present State Examination DSMIII MDD+MnD 50% USA 
Burvill et al 
(1995)  
4 1 1995 Y 294 72 Community Present State Examination DSMIII GAD 
Agoraphobia 
44% Australia 
Burvill et al 
(1995)  
4 1 1995 Y 248 72 Community Present State Examination DSMIII MDD+MnD 44% Australia 
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Burvill et al 
(1996) 
3 2 1996 Y 117 NR Community Psychiatric Assessment Schedule DSMIII MDD+MnD 42% Australia 
Burvill et al 
(1997) 
3 2 1997 Y 191 NR Community Psychiatric Assessment Schedule DSMIII MDD+MnD NR Australia 
Caeiro et al 
(2006) 
3 1 2006 N 178 56.8 Hospital inpatients SCID DSMIVTR MDD 40% Portugal 
Carota et al 
(2005)  
4 1 2005 N 246 66.4 Stroke rehabilitation unit in 
hospital 
SCID DSMIV MDD+MnD 47% Switzerland 
Cassidy et al 
(2004) 
3 1 2004 N 50 51.4 Stroke rehabilitation unit in 
hospital 
SCID DSMIV criteria 42% Ireland, UK 
Castillo et al 
(1993)  
4 1 1993 Y 309 58.9 Hospital inpatients Present State Examination DSMIII MDD 43.80% USA 
Castillo et al 
(1995)  
4 1 1995 Y 78 58.2 Hospital Outpatients Present State Examination DSMIII MDD 43% USA 
Chatterjee et al 
(2010) 
4 1 2010 Y 182 70 Community SCID DSMIV MDD+MnD NR UK 
Cumming et al 
(2010) 
3 2 2010 N 149 81 Hospital Outpatients Psychiatric diagnostic interview DSMIIIR MDD 65% Sweden, Australia 
Dam (2001) 3 1 2001 Y 99 57 Hospital or via telephone  Research Diagnostic criteria 
(RDC)  
DSMIIIR MDD 
+MnDD 
34% Denmark 
Fedoroff et al 
(1991) 
4 1 1991 Y 205 58.7 Hospital inpatients Present State Examination DSMIII MDD+MnD 48% USA 
Folstein et al 
(1977) 
2 2 1977 N 20 63.3 Rehabilitation Hospital Present State Examination (8th 
Edn) 
DSMII 55% USA 
Gainotti et al 
(1999) 
3 1 1999 N 153 62.3 Rehabilitation centre SCID DSMIII criteria 42% Italy 
Gonzalez-
Torrecillas et al 
(1995) 
4 1 1995 Y 130 67.58 Hospital inpatients SADS interview Research Diagnostic 
criteria (RDC)  
53.80% Spain 
Gordon et al 
(1991) 
4 1 1991 Y 116 67.83 Rehabilitation Hospital SCID DSMIII MDD+MnD 40.50% USA 
Grasso et al 
(1994) 
2 2 1994 Y 15 67.8 Rehabilitation centre Psychiatric diagnostic interview DSMIIIR 53.00% Italy 
Grober et al 
(1991) 
2 2 1991 N 29 66 Outpatient SCID DSMIII MDD NR USA 
Healey et al 
(2008) 
2 2 2008 N 49 55 Inpatient rehabilitation centre SCID DSMIV MDD 57.10% UK 
Herrmann et al 
(1995) 
2 2 1995 N 47 62 Stroke rehabilitation unit in 
hospital 
SCID DSMIIIR MDD 
+MnDD 
34% Germany 
Hibbard et al 
(1992) 
3 1 1992 Y 82 67.1 Inpatient and outpatient 
rehab programs in 3 New 
York Hospitals 
DSMIIIR diagnosis formulated 
using Structured Assessment of 
Depression in Brain-Damaged 
Individuals 
DSMIIIR MDD+MD 54% USA 
House et al 
(1990)  
4 1 1991 N 89 71.2 Community Present State Examination DSMIII MDD 55% UK 
House et al 
(2001) 
3 1 2001 Y  448 70.7 Community Present State Examination ICD10 criteria 46% UK 
Jimenez et al 
(2009) 
3 1 2009 Y 104 70.4 Stroke unit SCID DSMIV MD+MnD 33% Spain 
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Kaji et al (2006) 3 1 2006 Y 100 64.6 Hospital Inpatients SCID DSMIV MDD 39% Japan 
Kang et al 
(2012) [2weeks] 
4 1 2012 Y 423 64.5 Hospital Inpatients MINI International 
Neuropsychiatric Interview 
DSMIIIR MDD 
+MnDD 
42% Korea 
Kauhanen et al 
(1999)  
4 3 1999 N 101 65.8 Hospital 
inpatients+outpatients 
Psychiatric interview 
(unstructured) 
DSMIIIR MDD 
+MnDD 
43% Finland 
Kim et al (2000) 3 1 2000 Y 148 62 Hospital Outpatients SCID DSMIV MDD 36.50% South Korea 
Kulkantrakorn 
et al (2007)  
4 1 2007 Y 75 65.4 Stroke rehabilitation unit in 
hospital 
SCID CISR criteria for 
ICD10 
55% Thailand 
Laska et al 
(2007) 
[Aphasia] 
2 3 2007 N 60 74 Hospital inpatients Unstructured Clinical Interview DSMIV MDD+MnD 44.90% Sweden 
Lee et al (2007) 3 1 2007 Y 200 71.95 Stroke rehabilitation unit in 
hospital 
SCID DSMIV MDD 36% China 
Lee et al (2008) 2 3 2008 N 253 72.2 Hospital inpatients Unstructured Clinical Interview DSMIV MDD 37.20% Hong Kong 
Leentjens 
(2006) 
3 1 2006 NR 165 68.1 Hospital inpatients SCID (DSM-IV) DSMIV-R MDD 43.00% Netherlands 
Leppävuori et al 
(2003) 
3 1 2003 Y 277 70.7 Community Present State Examination DSMIV MDD 49.10% Finland 
Lincoln et al 
(2003)  
4 1 2003 N 143 66 Hospital Outpatients SCAN (DSM-IIIR) DSMIIIR MDD 49% UK 
Lipsey et al 
(1985) 
2 2 1985 Y 48 63.5 Rehabilitation Hospital Present State Examination DSMIII MDD 63% USA 
MacHale et al 
(1998) 
3 1 1998 Y 145 66 Hospital Outpatients Standardised semistructured 
psychiatric interview 
DSMIV MDD 48% UK 
Morris et al 
(1990)  
4 1 1990 N 99 70.8 Rehab hosp CIDI   DSMIII MDD+MnD 48% Australia 
Morris et al 
(1991) 
3 1 1991 Y 76 71.3 Rehab hosp CIDI   DSMIII MDD+MnD 47% Australia 
Morris et al 
(1992) 
3 1 1992   88 70 Rehab hosp CIDI   DSMIII MDD+MnD 45% Australia 
Morris et al 
(1994) 
3 1 1994 Y 94 70.6 Rehab hosp CIDI   DSMIII MDD+MnD 48% Australia 
Morris et al 
(1996) 
2 2 1996 N 41 70 Hospital Inpatients CIDI   DSMIIIR MDD 56% Australia 
Naarding et al 
(2002) 
2 2 2002 Y 44 70.3 Neurological ward inpatients SCID DSMIV MDD 36.40% Netherlands 
Nagaraja et al 
(1997) 
2 2 1997 Y 40 42.4 National Institute of Mental 
Health and Neuroscience 
(NIMHANS) 
Comprehensive psychiatric rating 
scale (CPRS), HDRS 
DSMIII-R 27.50% India 
Niedermaier et 
al (2004) 
3 1 2004 Y 70 64.95 Stroke rehabilitation unit in 
hospital 
Semi-structured interview DSMIV MDD 32.86% Germany 
O'Rourke et al 
(1998) 
3 1 1998 N 105 68 Hospital inpatients SADS interview DSMIV MDD NR UK 
Palomäki et al 
(1999) [ 
2 2 1999 N 49 54.7 Hospital inpatients SADS interview DSMIIIR MDD 34.70% Finland 
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Paolucci et al 
(2006) 
3 4 2005 N 1064 67.2 Hospital Outpatients Two Step Proceedure (BDI>10 
then SCID) 
DSMIV MDD+MnD 40% Italy 
Paradiso and 
Robinson 
(1998) 
4 1 1998 Y 301 58.94 Hospital inpatients Present State Examination DSMIV MDD+MnD 43.50% USA 
Paradiso and 
Robinson 
(1999) 
4 1 1999 Y 141 59.2 Hospital inpatients Present State Examination DSMIV MDD+MnD 40.60% USA 
Paradiso et al 
(1997) [ 
4 1 1997 Y 142 60.46 Hospital inpatients Present State Examination DSMIV MDD+MnD 44% USA 
Parikh et al 
(1988) 
3 1 1988 Y 80 58 Hospital Outpatients Present State Examination DSMIII MDD+MnD 22.20% US 
Pohjasvaara et 
al (1998) 
3 1 1998 Y 277 55-85 Hospital 
inpatients+outpatients 
SCID DSMIIIR MDD+MnD NR Finland 
Quaranta et al 
(2008) 
4 1 2008 Y 143 62.77 Inpatient rehabilitation unit SCID DSMIVTR 
MDD+MnD 
43% Italy 
Rao et al (2001) 2 3 2001 Y 25 >65 Community SCID DSMIV MDD NR UK 
Robinson et al 
(1983) 
4 1 1983 Y  103 59 Hospital inpatients Present State Examination DSMIII MDD+MnD 39% USA 
Roger et al 
(2009) 
3 1 2009 Y 67 71 Stroke rehabilitation unit 
inpatient hospital 
SCID DSMIV MDD+MnD 52.20% USA 
Rybarczyk et al 
(1996) 
2 3 1996 N 50 71 Inpatient rehabilitation unit Unstructured Clinical Interview DSMIII MDD+MnD NR USA 
Sachdev et al 
(2007) 
2 2 2007 N 47 72.02 Community SCID DSMIV 42.60% Australia 
Sagen et al 
(2009) 
4 1 2009 Y 104 64.5 Stroke unit in hospital SCID DSMIV MDD+MnD 41.30% Norway 
Santos et al 
(2009) 
2 3 2009 Y 41 77.46 Hospital Outpatients Unstructured Clinical Interview DSMIV MDD 49% Switzerland 
Schramke et al 
(1998) 
3 2 1998 N 44 64 Rehabilitation Hospital SCID DSMIIIR MDD 
+MnDD 
34% USA 
Schubert et al 
(1992) 
2 3 1992 Y 21 47-72 Rehab hosp Psychiatric diagnostic interview DSMIIIR MDD 52% USA 
Schultz et al 
(1997) 
3 1 1997 Y 142     Psychiatric diagnostic interview DSMIV 43% US 
Schwartz et al 
(1993) 
3 1 1993 Y 91 66 Rehab hosp Psychiatric diagnostic interview DSMIII MDD 0% USA 
Sharpe  et al 
(1990) 
3 1 1990 N 60 71 Community SCID DSMIIIR MDD+MnD 38% UK 
Shinar et al 
(1986) 
2 2 1986 Y 27 56 Outpatients/Inpatients Present State Examination DSMIII MDD+MnD 59.20% Israel 
Sivrioglu et al 
(2009) 
3 3 2009 Y 85 59 Rehabilitation or stroke unit Psychiatric interview 
(unstructured) 
DSMIV MDD+MnD 62.30% Turkey 
Spalletta et al 
(2002) 
4 1 2002 Y 153 66.26 Hospital Outpatients SCID DSMIV MDD+MnD 40% Italy 
Spalletta et al 
(2005) 
4 1 2005 Y 200 65.6 Hospital inpatients SCID DSMIV MDD+MnD 41% Italy 
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Srivastava et al 
(2010) 
2 3 2010 Y 51 46.06 Neurological rehabilitation 
unit 
Unstructured Clinical Interview ICD10 criteria 24% India 
Starkstein et al 
(1987) 
3 2 1987 Y 45 57.5 Hospital inpatients and rehab 
unit 
Present State Examination DSMIII MDD+MnD 35% USA 
Starkstein et al 
(1987) 
3 2 1987 Y 45 58.4 Acute and rehabilitation Present State Examination DSMIII MDD NR US 
Starkstein et al 
(1988) 
3 1 1988 Y 79 60.05 Hospital inpatients Present State Examination DSMIII MDD+MnD 36% USA 
Starkstein et al 
(1992) 
3 1 1992 Y 80 58.81 Hospital inpatients Present State Examination DSMIII MDD+MnD NR USA 
Stone et al 
(2004) 
2 2 2004 Y 35 72 Community / home SCID DSMIV MDD+MnD 32% UK 
Storer and 
Byrne (2006) 
3 1 2006 Y 61 71.9 Stroke unit in hospital SCID DSMIV MDD  59% Australia 
Tang et al 
(2002) 
4 1 2002 Y 157 71 Stroke rehabilitation unit in 
hospital 
SCID DSMIIIR MDD 
+MnDD 
55% China 
Tang et al 
(2004a) 
3 1 2004 Y 100 74 Rehabilitation Hospital SCID DSMIIIR Any 
depression (MDD, 
dysthymia, or 
adjustment disorder 
with depressed 
mood) 
45% Hong Kong 
Tang et al 
(2004c) 
3 1 2004 Y 60 71 Hospital inpatients SCID DSMIIIR 
MDD+MnDD+Dys 
55% Hong Kong 
Tang et al 
(2005) 
4 1 2005 Y 189 68.1 Hospital Outpatients SCID DSMIV MDD+MnD 40.70% China 
Tang et al 
(2011) 
4 1 2011 Y 591 66 Stroke unit in hospital SCID DSMIV MDD+MnD 39.10% China, Australia 
Terroni et al 
(2009) 
3 1 2009 Y 73 48.7 Neurological rehabilitation 
unit 
SCID DSMIV MDD 42.50% Brazil 
Terroni et al 
(2011)  
4 1 2011 Y 68 51.03 Neurological rehabilitation 
unit 
SCID DSMIV MDD 47% Brazil 
Turner et al 
(2012) 
3 1 2012 N 72 67 Hospital Outpatients SCID DSMIV MDD 47.20% Australia 
Van de Weg et 
al (1999) 
3 1 1999 Y 85 61.4 Rehabilitation centre SCID DSMIII MDD 51% Netherlands 
Van Ginkel et al 
(2012) 
3 1 2012 Y 164 71 Hospital inpatients CIDI   DSMIV MDD 40.90% Netherlands 
Vataja et al 
(2001) 
4 1 2001 Y 275 70.7 Community + Hospital Present State Examination DSMIV MDD+MnD 49.00% Finland 
Williams et al 
(2005) 
3 1 2005 Y  316 59 Hospital Outpatients SCID DSMIV MDD 46% USA 
Yang et al 
(2010) [2weeks] 
2 3 2010 Y 100 68.95 Neurology Dept Unstructured Clinical Interview DSM IV 51% China 
Zhang et al 
(2012) 
3 2 2012 Y 163 18-80yrs 
(no 
mean) 
Neurology Dept SCID DSMIV MD+MnD NR China 
Zhou et al 
(2010) 
2 3 2010 Y 93 62.6 Neurology Dept Unstructured Clinical Interview DSMIV  44% China 
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Graphical abstract 
Figure – Meta-regression on major depression and time since stroke 
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Highlights 
We conducted a meta-analysis of 128 studies involving 15,573 patients follow a stroke. 
The point prevalence of major depression was 17.7% (95% CI = 15.6% to 20.0%). 
Any form of depression (ADD) was present in 33.5% (95% CI = 30.3% to 36.8%).  
Risk of depression was higher after left hemisphere stroke, aphasia, and past history of mood 
disorders.  
 
References 
                                                 
1
 Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco 
RL et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of 
Disease Study 2010. Lancet. 2014 Jan 18;383(9913):245-54. 
 
2
 Lee S, Shafe AC, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 
1999-2008: time-trend analysis from the General Practice Research Database. BMJ Open. 2011 Jan 
1;1(2):e000269. 
 
3
 Ayerbe L, Ayis S, Rudd AG, Heuschmann PU, Wolfe CD. Natural history, predictors, and associations 
of depression 5 years after stroke: the South London Stroke Register. Stroke. 2011 Jul;42(7):1907-11.  
 
4
 Chemerinski E, Robinson RG, Kosier JT. Improved recovery in activities of daily living associated with 
remission of post-stroke depression. Stroke 2001; 32:113-117. 
 
5
 Lo RS, Cheng JO, Wong EM, Tang WK, Wong LK, Woo J. Handicap and its determinants of change in 
stroke survivors: One-year follow-up study. Stroke 2008; 39: 148–153. 
 
6
 Schmid AA, Kroenke K, Hendrie HC, Bakas T, Sutherland JM, Williams LS. Poststroke depression and 
treatment effects on functional outcomes. Neurology. 2011 Mar 15;76(11):1000-5. 
 
7
 Hilari K, Needle JJ, Harrison KL. What are the important factors in health-related quality of life for 
people with aphasia? A systematic review. Arch Phys Med Rehabil. 2012 Jan;93(1 Suppl):S86-95. doi: 
10.1016/j.apmr.2011.05.028. Epub 2011 Nov 25. 
 
8
 Gump BB, Matthews KA, Eberly LE, Chang YF. For the MRG Depressive symptoms and mortality in 
men: results from the Multiple Risk Factor Intervention Trial. Stroke 2005; 36: 98-102. 
 
9
 House A, Knapp P, Bamford J, Vail A. Mortality at 12 and 24 months after stroke maybe associated 
with depressive symptoms at 1 month. Stroke 2001; 32:696-701. 
 
10
 van de Weg FB, Kuik DJ, Lankhorst GJ. Post-stroke depression and functional outcome: a cohort 
study investigating the influence of depression on functional recovery from stroke. Clin Rehabil. 1999 
Jun;13(3):268-72. 
 
11
 Nannetti L, Paci M, Pasquini J, Lombardi B, Taiti PG. Motor and functional recovery in patients with 
post-stroke depression. Disabil Rehabil. 2005; 27(4):170-5. 
 
12
 Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of post-stroke 
depression- a three-month double-blind placebo-controlled study with an open-label long-term 
follow up. J Neurol. 2003 Mar;250(3):347-51. 
 
13
 Dong JY, Zhang YH, Tong J, Qin LQ. Depression and risk of stroke: a meta-analysis of prospective 
studies. Stroke. 2012 Jan;43(1):32-7. Epub 2011 Oct 20. 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
32 
                                                                                                                                            
14
 Williams CL, Rittman MR, Boylstein C, Faircloth C, Haijing Q. Qualitative and quantitative 
measurement of depression in veterans recovering from stroke. Journal of Rehabilitation Research 
and Development 2005; 42: 277-290. 
 
15
 Singh A, Herrmann N, Black S. The importance of lesion location in poststroke depression: A critical 
review. Can J Psychiatry 1998;43:921-927. 
 
 
16
 Narushima K, Kosier JT, Robinson RG. A reappraisal of poststroke depression, intra- and inter-
hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci. 2003 Fall;15(4):422-
30. 
 
17
 Carson AJ, McHale S, Allen K, Lawrie SM, Dennis M, House A, Sharpe M. Depression after stroke and 
lesion location: A systematic review. Lancet 2000;356:122- 
126. 
 
18
 Bhogal SK, Teasell R, Foley N, Speechley M. Lesion Location and Poststroke Depression: Systematic 
Review of the Methodological Limitations in the Literature. Stroke 2004;35:794-802. 
 
19
 Kouwenhoven SE, Kirkevold M, Engedal K, Kim HS. Depression in acute stroke: prevalence, 
dominant symptoms and associated factors. A systematic literature review. Disabil Rehabil. 
2011;33(7):539-56. Epub 2010 Aug 7. 
 
20
 Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic 
review of observational studies. Stroke. 2005 Jun;36(6):1330-40. Epub 2005 May 5. 
 
21
 Ayerbe L, Ayis S, Wolfe CD, Rudd AG. Natural history, predictors and outcomes of depression after 
stroke: systematic review and meta-analysis. Br J Psychiatry. 2013 Jan;202(1):14-21. doi: 
10.1192/bjp.bp.111.107664. 
 
22
 Campbell Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P. Frequency of anxiety after 
stroke: a systematic review and meta-analysis of observational studies. Int J Stroke. 2013 
Oct;8(7):545-59. doi: 10.1111/j.1747-4949.2012.00906.x. Epub 2012 Sep 27. 
 
23
 Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, 
Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-
analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15):2008-2012 
 
24
 Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic 
reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 
10.1371/journal.pmed.1000097. Epub 2009 Jul 21. 
 
25
 Dr Benita Cox; Prof. James Barlow; Dr Christina Petsoulas; Dr Steffen Bayer. Modelling Service 
Innovation In Stroke Care Imperial College Report 
 
26 Chan DKY, Cordato D, O'Rourke F et al.Comprehensive stroke units: a review of comparative 
evidence and experience. International Journal of Stroke Early View 
 
27
 Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. Prevalence of depression, 
anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-
analysis of 94 interview-based studies. Lancet Oncol. 2011 Feb;12(2):160-74. Epub 2011 Jan 19. 
 
28
 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 
2003 Sep 6;327(7414):557-60. 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
33 
                                                                                                                                            
29
 Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of 
controlled trials with binary endpoints. Stat Med. 2006 Oct 30;25(20):3443-57. 
 
30 Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet. 
2009 Aug 22;374(9690):609-19. doi: 10.1016/S0140-6736(09)60879-5. Epub 2009 Jul 27. 
 
31 Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. Prevalence of depression, 
anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-
analysis of 94 interview-based studies. Lancet Oncol. 2011 Feb;12(2):160-74. doi: 10.1016/S1470-
2045(11)70002-X. Epub 2011 Jan 19. 
 
32 Pietrzak RH, Kinley J, Afifi TO, Enns MW, Fawcett J, Sareen J. Subsyndromal depression in the 
United States: prevalence, course, and risk for incident psychiatric outcomes. Psychol Med. 2012 Oct 
31:1-14. [Epub ahead of print] 
 
33 Leppävuori A, Pohjasvaara T, Vataja R, Kaste M, Erkinjuntti T. Generalized anxiety disorders three 
to four months after ischemic stroke. Cerebrovasc Dis. 2003;16(3):257-64. 
 
34 Carota A, Berney A, Aybek S, et al. A prospective study of predictors of poststroke depression. 
Neurology 2005;64:428-433. 
 
35 Christensen MC, Mayer SA, Ferran JM, Kissela B. Depressed mood after intracerebral hemorrhage: 
the FAST trial. Cerebrovasc Dis 2009;27(4):353-60. 
 
36 Bour A, Rasquin S, Aben I, Boreas A, Limburg M, Verhey F: A one-year follow-up study into the 
course of depression after stroke. J Nutr Health Aging 2010;14:488-493. 
 
37 White CL, McClure LA, Wallace PM, Braimah J, Liskay A, Roldan A, Benavente OR; SPS3 
Investigators. The correlates and course of depression in patients with lacunar stroke: results from 
the Secondary Prevention of Small Subcortical Strokes (SPS3) study. Cerebrovasc Dis. 2011;32(4):354-
60. Epub 2011 Sep 15. 
 
38 Lipsey JR, Spencer WC, Rabins PV, Robinson RG. Phenomenological comparison of poststroke 
depression and functional depression. Am J Psychiatry. 1986; 143:527-9. 
 
39 Anderson G, Vestegaard K, Riis J, Lauritzen L. Incidence of post-stroke depression during the first 
year in a large unselected stroke population determined using a valid standardized rating scale. Acta 
Psychiatric Scandinavica 1994; 90:190-195. 
 
40 Bowen A, Knapp P, Hoffman A, Lowe D. Psychological services for people with stroke: compliance 
with the U.K. National Clinical Guidelines. Clin Rehabil 2005;19:323-330. 
 
ACCEPTED MANUSCRIPT
